Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Inventiva S.A.

Inventiva S.A. (IVA) Stock Overview

Explore Inventiva S.A.’s financial performance, market position, analyst ratings, and future outlook.

IVA●NASDAQ
HealthcareBiotechnology
$3.29
$0.24(6.80%)
U.S. Market opens in 13h 48m

Inventiva S.A. (IVA)

Meyka AI Score

Z

Key Financials

Market Cap171M
P/E Ratio-6.16
EPS (TTM)$-2.96
ROE12.89%
Fundamental Analysis

AI Price Forecasts

1 Month$2.61
3 Months$3.01
1 Year Target$6.39

IVA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Inventiva S.A. (NASDAQ: IVA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Inventiva S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IVA on the NASDAQ shows an RSI of 27.65, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $6.39 for the NASDAQ listing.

Key metrics behind Inventiva S.A.'s NASDAQ-traded stock include a P/E ratio of -6.16 and a market capitalization of 171M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IVA on the NASDAQ.

Price Performance (NASDAQ: IVA)

1-Day Change
-6.80%
5-Day Change
-2.66%
1-Month Change
-30.15%
3-Month Change
-7.32%
6-Month Change
-42.48%
Year-to-Date (YTD) Change
-29.25%
1-Year Change
-43.95%
3-Year Change
-21.67%
5-Year Change
-77.15%
All-Time (Max) Change
-75.48%

Contact Information

https://www.inventivapharma.com
33 3 80 44 75 00
50 rue de Dijon, Daix, BF, 21121

Company Facts

730 Employees
IPO DateJul 10, 2020
CountryFR
Actively Trading

Frequently Asked Questions